Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of paracetamol + phenylephrine + chlorpheniramine for flu and common cold
RBR-8ppyzb2Phase 3Not yet recruiting
- Sponsor
- Scentryphar Pesquisa Clínica
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetaminophen, phenylephrine and chlorpheniramine in influenza and nasopharyngitis (3 arms), sponsored by Scentryphar Pesquisa Clínica. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
acetaminophenphenylephrinechlorpheniramine
03
Conditions
influenzanasopharyngitis
Beyond the preview
Go deeper on RBR-8ppyzb2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8ppyzb2.